161 related articles for article (PubMed ID: 28438487)
21. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
22. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
23. HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology.
Shrestha R; Hodzic E; Sauerwald T; Dao P; Wang K; Yeung J; Anderson S; Vandin F; Haffari G; Collins CC; Sahinalp SC
Genome Res; 2017 Sep; 27(9):1573-1588. PubMed ID: 28768687
[TBL] [Abstract][Full Text] [Related]
24. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract][Full Text] [Related]
25. FocalScan: Scanning for altered genes in cancer based on coordinated DNA and RNA change.
Karlsson J; Larsson E
Nucleic Acids Res; 2016 Nov; 44(19):e150. PubMed ID: 27474725
[TBL] [Abstract][Full Text] [Related]
26. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
[TBL] [Abstract][Full Text] [Related]
27. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
28. Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer.
Brown DN; Caffa I; Cirmena G; Piras D; Garuti A; Gallo M; Alberti S; Nencioni A; Ballestrero A; Zoppoli G
Sci Rep; 2016 Jan; 6():19435. PubMed ID: 26777065
[TBL] [Abstract][Full Text] [Related]
29. Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers.
Shi W; Balazs B; Györffy B; Jiang T; Symmans WF; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2014 Apr; 144(3):561-8. PubMed ID: 24619174
[TBL] [Abstract][Full Text] [Related]
30. Identifying mutated driver pathways in cancer by integrating multi-omics data.
Wu J; Cai Q; Wang J; Liao Y
Comput Biol Chem; 2019 Jun; 80():159-167. PubMed ID: 30959272
[TBL] [Abstract][Full Text] [Related]
31. FGMD: A novel approach for functional gene module detection in cancer.
Jin D; Lee H
PLoS One; 2017; 12(12):e0188900. PubMed ID: 29244808
[TBL] [Abstract][Full Text] [Related]
32. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
Guest ST; Kratche ZR; Bollig-Fischer A; Haddad R; Ethier SP
Exp Cell Res; 2015 Mar; 332(2):223-35. PubMed ID: 25704758
[TBL] [Abstract][Full Text] [Related]
33. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Roszik J; Wu CJ; Siroy AE; Lazar AJ; Davies MA; Woodman SE; Kwong LN
Sci Rep; 2016 Jan; 6():19649. PubMed ID: 26787600
[TBL] [Abstract][Full Text] [Related]
34. Integration of genomic data enables selective discovery of breast cancer drivers.
Sanchez-Garcia F; Villagrasa P; Matsui J; Kotliar D; Castro V; Akavia UD; Chen BJ; Saucedo-Cuevas L; Rodriguez Barrueco R; Llobet-Navas D; Silva JM; Pe'er D
Cell; 2014 Dec; 159(6):1461-75. PubMed ID: 25433701
[TBL] [Abstract][Full Text] [Related]
35. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
36. Identifying master regulators of cancer and their downstream targets by integrating genomic and epigenomic features.
Gevaert O; Plevritis S
Pac Symp Biocomput; 2013; ():123-34. PubMed ID: 23424118
[TBL] [Abstract][Full Text] [Related]
37. The landscape of candidate driver genes differs between male and female breast cancer.
Johansson I; Ringnér M; Hedenfalk I
PLoS One; 2013; 8(10):e78299. PubMed ID: 24194916
[TBL] [Abstract][Full Text] [Related]
38. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
Merid SK; Goranskaya D; Alexeyenko A
BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
[TBL] [Abstract][Full Text] [Related]
39. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
40. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
